Related Experiment Video
Updated: Sep 23, 2025

05:58
Tissue Triage and Freezing for Models of Skeletal Muscle Disease
Published on: July 15, 2014
40.5K
A pathogenic mechanism associated with myopathies and structural birth defects involves TPM2-directed myogenesis
Jennifer McAdow1, Shuo Yang1, Tiffany Ou1
1Department of Developmental Biology, Washington University in St. Louis, St. Louis, Missouri, USA.
JCI Insight
|May 17, 2022
Summary
Pathogenic variants in Tropomyosin 2 (TPM2) cause muscle disorders. This study reveals disrupted myogenesis as a novel mechanism and demonstrates that zebrafish assays can predict disease severity in patients.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- Nemaline myopathy (NM) is a congenital myopathy caused by genetic variants.
- Tropomyosin 2 (TPM2) variants lead to a range of musculoskeletal disorders, including NM and distal arthrogryposis (DA).
- The in vivo mechanisms of TPM2-related disorders remain largely unknown.
Purpose of the Study:
- To investigate the in vivo pathomechanisms of TPM2-related musculoskeletal disorders.
- To establish and validate myogenic assays for predicting clinical severity.
Main Methods:
- Expressed dominant pathogenic TPM2 variants in Drosophila embryos.
- Performed transient overexpression assays in mouse myotubes (in vitro) and zebrafish (in vivo).
- Characterized TPM2 variants identified in patients with distal arthrogryposis (DA).
Main Results:
- Four TPM2 variants significantly impaired muscle development and function in Drosophila.
- Overexpression of pathogenic TPM2 variants disrupted mouse myotube morphogenesis and zebrafish muscle development.
- Zebrafish assays with novel and recurring TPM2 variants mirrored patient-observed musculoskeletal defects.
Conclusions:
- Disrupted myogenesis is a potential novel pathomechanism in TPM2 disorders.
- Myogenic assays in model organisms can predict the clinical severity of TPM2 variants.
- This research provides insights into the molecular basis of congenital myopathies and related disorders.
Related Concept Videos
Formation of Muscle Fibers from Myoblasts
5.2K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.2K
Translocation of Proteins into the Mitochondria
4.7K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
4.7K
Microtubule Associated Proteins (MAPs)
4.6K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
ATP Synthase: Mechanism
15.3K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.3K

